- Biotech degrees / certificates
- Event Materials
- Photo Gallery
HER2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer
This book recounts the history of discovery of the Her 2 receptor and of the effort, mainly by Dennis Slamon of UCLA, to develop a monoclonal antibody as a therapeutic drug to treat the cases of breast cancer that overexpress this antigen. The publisher times the release of this book with the announcement of Herceptin's FDA approval. Herceptin was the first drug produced at Genentech's Vacaville manufacturing facility.
Reviewed by:Jim DeKloe